In line, MFN2, OPA1, or DRP1 deficiency negatively affect muscle health and mitochondrial homeostasis, triggering the insurgence of sarcopenia features, such as muscle atrophy [68,69,70]. The gene discussed is DNM1L; the disease is sarcopenia.